Barriers and Facilitators to Implementing Interventions for Reducing Avoidable Hospital Readmission: Systematic Review of Qualitative Studies.

Delivery of Healthcare Implementation Science Patient Readmission Qualitative Research Systematic Review Transitional Care

Journal

International journal of health policy and management
ISSN: 2322-5939
Titre abrégé: Int J Health Policy Manag
Pays: Iran
ID NLM: 101619905

Informations de publication

Date de publication:
2023
Historique:
received: 11 02 2022
accepted: 04 01 2023
medline: 16 8 2023
pubmed: 14 8 2023
entrez: 14 8 2023
Statut: ppublish

Résumé

Avoidable hospital readmission is a major problem among health systems. Although there are effective peri-discharge interventions for reducing avoidable hospital readmission, successful implementation is challenging. This systematic review of qualitative studies aimed to identify barriers and facilitators to implementing peri-discharge interventions from providers' and service users' perspectives. We searched four databases for potentially eligible qualitative studies from databases' inception to March 2020, and updated literature search for studies published between January 2020 to October 2021. Barriers and facilitators to implementing peri-discharge interventions were identified and mapped onto the Consolidated Framework for Implementation Research (CFIR) constructs. Inductive analysis of the CFIR constructs was performed to yield thematic areas that illustrated the relationship between various facilitators and barriers, generating practical insights to key implementation issues. Thirteen qualitative studies were included in this systematic review. Key issues were clustered in the CFIR constructs of This study synthesized commonly-presenting barriers and facilitators to implementing peri-discharge interventions among different healthcare organizations. Findings may inform development of implementation strategies in different health systems after appropriate tailoring, based on a consensus-based formative research process.

Sections du résumé

BACKGROUND
Avoidable hospital readmission is a major problem among health systems. Although there are effective peri-discharge interventions for reducing avoidable hospital readmission, successful implementation is challenging. This systematic review of qualitative studies aimed to identify barriers and facilitators to implementing peri-discharge interventions from providers' and service users' perspectives.
METHODS
We searched four databases for potentially eligible qualitative studies from databases' inception to March 2020, and updated literature search for studies published between January 2020 to October 2021. Barriers and facilitators to implementing peri-discharge interventions were identified and mapped onto the Consolidated Framework for Implementation Research (CFIR) constructs. Inductive analysis of the CFIR constructs was performed to yield thematic areas that illustrated the relationship between various facilitators and barriers, generating practical insights to key implementation issues.
RESULTS
Thirteen qualitative studies were included in this systematic review. Key issues were clustered in the CFIR constructs of
CONCLUSION
This study synthesized commonly-presenting barriers and facilitators to implementing peri-discharge interventions among different healthcare organizations. Findings may inform development of implementation strategies in different health systems after appropriate tailoring, based on a consensus-based formative research process.

Identifiants

pubmed: 37579466
doi: 10.34172/ijhpm.2023.7089
pii: 7089
pmc: PMC10125127
doi:
pii:

Types de publication

Systematic Review Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

7089

Informations de copyright

© 2023 The Author(s); Published by Kerman University of Medical Sciences This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Références

JBI Database System Rev Implement Rep. 2016 Apr;14(4):96-137
pubmed: 27532314
Implement Sci. 2009 Aug 07;4:50
pubmed: 19664226
Am J Manag Care. 2011 Jan;17(1):41-8
pubmed: 21348567
BMJ. 2017 Mar 6;356:i6795
pubmed: 28264797
BMC Med Inform Decis Mak. 2005 Mar 22;5:8
pubmed: 15784134
Implement Sci. 2018 Mar 1;13(1):38
pubmed: 29490671
Implement Sci. 2015 Feb 12;10:21
pubmed: 25889199
PLoS One. 2022 May 11;17(5):e0267533
pubmed: 35544529
Implement Sci. 2017 Nov 14;12(1):132
pubmed: 29137659
Healthc (Amst). 2021 Mar;9(1):100518
pubmed: 33412440
BMC Med Res Methodol. 2013 Mar 13;13:37
pubmed: 23497061
BMC Health Serv Res. 2020 Mar 27;20(1):256
pubmed: 32220252
J Clin Nurs. 2019 Mar;28(5-6):745-761
pubmed: 30376199
Int J Integr Care. 2022 Feb 03;22(1):7
pubmed: 35136388
Am J Med Qual. 2017 Jul/Aug;32(4):353-360
pubmed: 27418618
PLoS One. 2021 Jan 20;16(1):e0245650
pubmed: 33471837
BMC Med Res Methodol. 2012 Nov 27;12:181
pubmed: 23185978
Health Aff (Millwood). 2018 Oct;37(10):1632-1639
pubmed: 30273024
Psychiatr Serv. 2020 Nov 1;71(11):1179-1187
pubmed: 32933410
Ann Intern Med. 2010 Dec 7;153(11):757-8
pubmed: 21135299
Implement Sci. 2016 May 17;11:72
pubmed: 27189233
Health Res Policy Syst. 2019 Nov 27;17(1):91
pubmed: 31775771
BMJ Open. 2015 Oct 09;5(10):e008251
pubmed: 26453590
BMC Med Res Methodol. 2007 Nov 29;7:52
pubmed: 18045508
Stud Health Technol Inform. 2004;107(Pt 1):311-6
pubmed: 15360825
J Am Med Dir Assoc. 2015 Aug 1;16(8):648-53
pubmed: 25833386
Clin Med (Lond). 2011 Apr;11(2):114-8
pubmed: 21526689
J Hosp Med. 2020 Sep;15(9):518-525
pubmed: 32195655
Implement Sci. 2018 Feb 23;13(1):36
pubmed: 29475440
J Clin Epidemiol. 2018 May;97:70-78
pubmed: 29242095
Implement Sci. 2017 Feb 10;12(1):15
pubmed: 28187747
Int J Nurs Stud. 2021 May;117:103904
pubmed: 33691220
JAMA Cardiol. 2018 Jan 1;3(1):44-53
pubmed: 29128869
BMC Med. 2011 Apr 14;9:39
pubmed: 21492447
Perspect Public Health. 2022 Sep;142(5):263-277
pubmed: 33719733
J Healthc Qual. 2016 Mar-Apr;38(2):116-26
pubmed: 26042743
Am J Infect Control. 2019 Apr;47(4):366-370
pubmed: 30503626
Annu Rev Med. 2014;65:471-85
pubmed: 24160939
BMC Med Res Methodol. 2009 Aug 11;9:59
pubmed: 19671152
J Am Med Dir Assoc. 2017 Nov 1;18(11):991.e11-991.e15
pubmed: 28967602
J Hosp Med. 2013 Nov;8(11):619-26
pubmed: 24124032
Milbank Q. 2004;82(4):581-629
pubmed: 15595944
Implement Sci. 2019 May 6;14(1):47
pubmed: 31060625
JAMA Intern Med. 2014 Jul;174(7):1095-107
pubmed: 24820131

Auteurs

Becky Q Fu (BQ)

Centre for Health Systems and Policy Research, Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, Shatin, Hong Kong.

Claire Cw Zhong (CC)

Centre for Health Systems and Policy Research, Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, Shatin, Hong Kong.

Charlene Hl Wong (CH)

Centre for Health Systems and Policy Research, Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, Shatin, Hong Kong.

Fai Fai Ho (FF)

School of Chinese Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong.

Per Nilsen (P)

Department of Medicine, Health and Caring Sciences, Linköping University, Linköping, Sweden.

Chi Tim Hung (CT)

Centre for Health Systems and Policy Research, Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, Shatin, Hong Kong.

Eng Kiong Yeoh (EK)

Centre for Health Systems and Policy Research, Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, Shatin, Hong Kong.

Vincent Ch Chung (VC)

Centre for Health Systems and Policy Research, Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, Shatin, Hong Kong.
School of Chinese Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH